HSAQ
Income statement / Annual
Last year (2022), Health Sciences Acquisitions Corporation 2's total revenue was $0.00,
and the percentage change from the previous year is not available.
In 2022, Health Sciences Acquisitions Corporation 2's net income was -$2.39 M.
See Health Sciences Acquisitions Corporation 2,s key income statements, including revenue, expenses, profit, and income.
| Period |
FY-2022
|
FY-2021
|
FY-2020
|
| Period Ended |
12/31/2022 |
12/31/2021 |
12/31/2020 |
| Operating Revenue |
$0.00 |
$0.00 |
$0.00 |
| Cost of Revenue |
$0.00
|
$0.00
|
$0.00
|
| Gross Profit |
$0.00
|
$0.00
|
$0.00
|
| Gross Profit Ratio |
0
|
0
|
0
|
| Research and Development Expenses |
$0.00
|
$0.00
|
$0.00
|
| General & Administrative Expenses |
$2.96 M
|
$274,756.00
|
$129,986.00
|
| Selling & Marketing Expenses |
$0.00
|
$0.00
|
$0.00
|
| Selling, General & Administrative Expenses |
$2.96 M
|
$274,756.00
|
$129,986.00
|
| Other Expenses |
$0.00
|
$0.00
|
$50,000.00
|
| Operating Expenses |
$2.96 M
|
$274,756.00
|
$179,986.00
|
| Cost And Expenses |
$2.96 M
|
$274,756.00
|
$179,986.00
|
| Interest Income |
$345,141.00
|
$16,003.00
|
$0.00
|
| Interest Expense |
-$345,141.00
|
-$16,003.00
|
$0.00
|
| Depreciation & Amortization |
$345,141.00
|
$16,003.00
|
$206,297.00
|
| EBITDA |
-$2.74 M |
-$378,753.00 |
-$173,542.00 |
| EBITDA Ratio |
0
|
0
|
0
|
| Operating Income Ratio |
0
|
0
|
0
|
| Total Other Income/Expenses Net |
$345,141.00
|
$16,003.00
|
$0.00
|
| Income Before Tax |
-$2.74 M
|
-$378,753.00
|
-$173,542.00
|
| Income Before Tax Ratio |
0
|
0
|
0
|
| Income Tax Expense |
-$345,141.00
|
-$16,003.00
|
$0.00
|
| Net Income |
-$2.39 M
|
-$362,750.00
|
-$173,542.00
|
| Net Income Ratio |
0
|
0
|
0
|
| EPS |
-0.15 |
-0.0179 |
-0.0086 |
| EPS Diluted |
-0.15 |
-0.0179 |
-0.0086 |
| Weighted Average Shares Out |
$16.43 M
|
$20.27 M
|
$20.27 M
|
| Weighted Average Shares Out Diluted |
$16.43 M
|
$20.27 M
|
$20.27 M
|
| Link |
|
|
|
